Chronic Kidney Disease

  • Girish N. NadkarniEmail author
  • Joseph A. Vassalotti


Chronic kidney disease (CKD) affects 10–15 % of individuals in industrialized nations and is associated with adverse morbidity and mortality. CKD has many etiologies, although the most common are diabetes and hypertension. In absence of a specific therapy for most causes of CKD, lifestyle modifications are at the forefront in prevention and treatment of this chronic disease that interacts with other chronic diseases characteristic of unhealthy diets, sedentary lifestyle, and aging. This chapter reviews the available evidence for lifestyle interventions targeting the full spectrum of CKD, including healthy diet, physical activity, adequate sleep, and tobacco cessation.


Chronic kidney disease Proteinuria Dialysis Exercise Nutrition Sleep Lifestyle 



Angiotensin-converting enzyme


American Diabetes Association


Acute kidney injury


Angiotensin receptor blockers


Blood pressure


Biological value


Blood urea nitrogen


Chronic kidney disease


Estimated glomerular filtration rate


End-stage renal disease


Gomerular filtration rate




Healthy Eating Index


Kidney disease quality outcomes initiative


Medical Nutrition Therapy


Obstructive sleep apnea


Peritoneal dialysis


Pittsburgh Sleep Quality Index


Polyunsaturated fatty acids


Rapid assessment of physical activity


Registered dietitian




Type-2 diabetes


Urine albumin/creatinine ratio


  1. 1.
    Levey AS, Stevens LA, Coresh J. Conceptual model of CKD: applications and implications. Am J Kidney Dis. 2009;53(3 Suppl 3):S4–16.CrossRefPubMedGoogle Scholar
  2. 2.
    Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713–35.CrossRefPubMedGoogle Scholar
  3. 3.
    Botdorf J, Chaudhary K, Whaley-Connell A. Hypertension in cardiovascular and kidney disease. Cardiorenal Med. 2011;1(3):183–92.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    James PA, Oparil S, Carter BL, et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.CrossRefPubMedGoogle Scholar
  5. 5.
    Centers for Disease Control and Prevention (CDC). Application of lower sodium intake recommendations to adults–United States, 1999–2006. MMWR Morb Mortal Wkly Rep. 2009;58(11):281–3.Google Scholar
  6. 6.
    Khatri M, Moon YP, Scarmeas N, Gu Y, et al. The association between a Mediterranean-style diet and kidney function in the Northern Manhattan Study cohort. Clin J Am Soc Nephrol. 2014;9(11):1868–75.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight loss on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42(5):878–84.CrossRefPubMedGoogle Scholar
  8. 8.
    American Diabetes Association. Glycemic targets. Sec. 6. In standards of medical care in diabetes—2015. Diabetes Care. 2015;38(Suppl 1):S33–40.CrossRefGoogle Scholar
  9. 9.
    The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86.CrossRefGoogle Scholar
  10. 10.
    Colberg SR, Sigal RJ, Fernhall B, American College of Sports Medicine, American Diabetes Association, et al. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care. 2010;33(12):2692–6.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Dunkler D, Dehghan M, Teo KK, ONTARGET Investigators, et al. Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus. JAMA Intern Med. 2013;173(18):1682–92.Google Scholar
  12. 12.
    Handelsman Y, Mechanick JI, Blonde L, American Association of Clinical Endocrinologists, et al. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011;17(Suppl 2):1–53.CrossRefPubMedGoogle Scholar
  13. 13.
    Gonzalez-Campoy JM, Jeor ST St, Castorino K, American Association of Clinical Endocrinologists, American College of Endocrinology and the Obesity Society, et al. Clinical practice guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults: cosponsored by the American Association of Clinical Endocrinologists/the American College of Endocrinology and the Obesity Society. Endocr Pract. 2013;19(Suppl 3):1–82.CrossRefPubMedGoogle Scholar
  14. 14.
    Miller CK, Kristeller JL, Headings A, Nagaraja H. Comparison of a mindful eating intervention to a diabetes self-management intervention among adults with type 2 diabetes: a randomized controlled trial. Health Educ Behav. 2014;41(2):145–54.CrossRefPubMedGoogle Scholar
  15. 15.
    Painter P, Roshanravan B. The association of physical activity and physical function with clinical outcomes in adults with chronic kidney disease. Curr Opin Nephrol Hypertens. 2013;22(6):615–23.CrossRefPubMedGoogle Scholar
  16. 16.
    Heiwe S, Jacobson SH. Exercise training for adults with chronic kidney disease. Cochrane Database Syst Rev. 2011;5(10):CD003236.Google Scholar
  17. 17.
    Chen IR, Wang SM, Liang CC, et al. Association of walking with survival and RRT among patients with CKD stages 3–5. Clin J Am Soc Nephrol. 2014;9(7):1183–9.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Topolski TD, LoGerfo J, Patrick DL, Williams B, Walwick J, Patrick MB. The rapid assessment of physical activity (RAPA) among older adults. Prev Chronic Dis. 2006;3(4):A118.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Park J, Lyles RH, Bauer-Wu S. Mindfulness meditation lowers muscle sympathetic nerve activity and blood pressure in African-American males with chronic kidney disease. Am J Physiol Regul Integr Comp Physiol. 2014;307(1):R93–101.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    McMahon EJ, Bauer JD, Hawley CM, Isbel NM, Stowasser M, Johnson DW, Campbell KL. A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol. 2013;24(12):2096–103.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    National Kidney Foundation. KDOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis. 2000;35(Suppl 2):S1–136.Google Scholar
  22. 22.
    Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int. 1985;27(1):58–65.CrossRefPubMedGoogle Scholar
  23. 23.
    Miller ER 3rd, Juraschek SP, Appel LJ, et al. The effect of n-3 long-chain polyunsaturated fatty acid supplementation on urine protein excretion and kidney function: meta-analysis of clinical trials. Am J Clin Nutr. 2009;89(6):1937–45.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Ricardo AC, Madero M, Yang W, et al. Adherence to a healthy lifestyle and all-cause mortality in CKD. Clin J Am Soc Nephrol. 2013;8(4):602–9.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Goraya N, Simoni J, Jo CH, Wesson DE. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate. Kidney Int. 2014;86(5):1031–8.CrossRefPubMedGoogle Scholar
  26. 26.
    Xu H, Huang X, Risérus U, et al. Dietary fiber, kidney function, inflammation, and mortality risk. Clin J Am Soc Nephrol. 2014;9(12):2104–10.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Krishnamurthy VM, Wei G, Baird BC, et al. High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int. 2012;81(3):300–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Ranganathan N, Friedman EA, Tam P, Rao V, Ranganathan P, Dheer R. Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada. Curr Med Res Opin. 2009;25(8):1919–30.CrossRefPubMedGoogle Scholar
  29. 29.
    Bomback AS, Katz R, He K, Shoham DA, Burke GL, Klemmer PJ. Sugar-sweetened beverage consumption and the progression of chronic kidney disease in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 2009;90(5):1172–8.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Huang X, Jimenez-Moleon JJ, Lindholm B, et al. Mediterranean diet, kidney function, and mortality in men with CKD. Clin J Am Soc Nephrol. 2013;8(9):1548–55.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Guenther PM, Kirkpatrick SI, Reedy J, et al. The Healthy Eating Index-2010 is a valid and reliable measure of diet quality according to the 2010 Dietary Guidelines for Americans. J Nutr. 2014;144(3):399–407.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Hallan S, de Mutsert R, Carlsen S, Dekker FW, Aasarød K, Holmen J. Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? Am J Kidney Dis. 2006;47(3):396–405.CrossRefPubMedGoogle Scholar
  33. 33.
    Sim JJ, Rasgon SA, Kujubu DA, et al. Sleep apnea in early and advanced chronic kidney disease: Kaiser Permanente Southern California cohort. Chest. 2009;135(3):710–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Kang EW, Abdel-Kader K, Yabes J, Glover K, Unruh M. Association of sleep-disordered breathing with cognitive dysfunction in CKD stages 4–5. Am J Kidney Dis. 2012;60(6):949–58.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Roumelioti ME, Ranpuria R, Hall M, et al. Abnormal nocturnal heart rate variability response among chronic kidney disease and dialysis patients during wakefulness and sleep. Nephrol Dial Transplant. 2010;25(11):3733–41.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Faulx MD, Storfer-Isser A, Kirchner HL, Jenny NS, Tracy RP, Redline S. Obstructive sleep apnea is associated with increased urinary albumin excretion. Sleep. 2007;30(7):923–9.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index (PSQI): a new instrument for psychiatric research and practice. Psychiatry Res. 1989;28(2):193–213.CrossRefPubMedGoogle Scholar
  38. 38.
    Yurtkuran M, Alp A, Yurtkuran M, Dilek K. A modified yoga-based exercise program in hemodialysis patients: a randomized controlled study. Complement Ther Med. 2007;15(3):164–71.CrossRefPubMedGoogle Scholar
  39. 39.
    Wizemann V, Wabel P, Chamney P, et al. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant. 2009;24(5):1574–9.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Chazot C. Can chronic volume overload be recognized and prevented in hemodialysis patients? Use of a restricted-salt diet. Semin Dial. 2009;22(5):482–6.CrossRefPubMedGoogle Scholar
  41. 41.
    Ozkahya M, Toz H, Unsal A, et al. Treatment of hypertension in dialysis patients by ultrafiltration: role of cardiac dilatation and time factor. Am J Kidney Dis. 1999;34(2):218–21.CrossRefPubMedGoogle Scholar
  42. 42.
    Dong J, Li Y, Yang Z, Luo J. Low dietary sodium intake increases the death risk in peritoneal dialysis. Clin J Am Soc Nephrol. 2010;5(2):240–7.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Kovesdy CP, Regidor DL, Mehrotra R, et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol. 2007;2(5):999–1007.CrossRefPubMedGoogle Scholar
  44. 44.
    Curtis CJ, Niederman SA, Kansagra SM. Availability of potassium on the nutrition facts panel of US packaged foods. JAMA Intern Med. 2013;173(9):828–9.CrossRefPubMedGoogle Scholar
  45. 45.
    Sherman RA, Mehta O. Potassium in food additives: something else to consider. J Ren Nutr. 2009;19(6):441–2.CrossRefPubMedGoogle Scholar
  46. 46.
    Cupisti A, Gallieni M, Rizzo MA, Caria S, Meola M, Bolasco P. Phosphate control in dialysis. Int J Nephrol Renovasc Dis. 2013;6:193–205.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Kestenbaum B, Sampson JN, Rudser KD, et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol. 2005;16(2):520–8.CrossRefPubMedGoogle Scholar
  48. 48.
    Sullivan C, Sayre SS, Leon JB, et al. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA. 2009;301(6):629–35.CrossRefPubMedGoogle Scholar
  49. 49.
    Bohn L, Meyer AS, Rasmussen SK. Phytate: impact on environment and human nutrition. A challenge for molecular breeding. J Zhejiang Univ Sci B. 2008;9(3):165–91.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Cupisti A, Morelli E, D’Alessandro C, Lupetti S, Barsotti G. Phosphate control in chronic uremia: don’t forget diet. J Nephrol. 2003;16(1):29–33.PubMedGoogle Scholar
  51. 51.
    Huang X, Stenvinkel P, Qureshi AR, et al. Clinical determinants and mortality predictability of stearoyl-CoA desaturase-1 activity indices in dialysis patients. J Intern Med. 2013;273(3):263–72.CrossRefPubMedGoogle Scholar
  52. 52.
    Friedman AN, Yu Z, Tabbey R, et al. Inverse relationship between long-chain n-3 fatty acids and risk of sudden cardiac death in patients starting hemodialysis. Kidney Int. 2013;83(6):1130–5.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Liebman SE, Lamontagne SP, Huang LS, Messing S, Bushinsky DA. Smoking in dialysis patients: a systematic review and meta-analysis of mortality and cardiovascular morbidity. Am J Kidney Dis. 2011;58(2):257–65.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Division of Nephrology, Department of MedicineIcahn School of Medicine at Mount SinaiNew YorkUSA
  2. 2.National Kidney Foundation, Inc.New YorkUSA

Personalised recommendations